BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bellon A, Nguyen K. Selective serotonin reuptake inhibitors and risk reduction for cardiovascular disease in patients with schizophrenia: A controversial but promising approach. World J Psychiatr 2021; 11(7): 316-324 [PMID: 34327124 DOI: 10.5498/wjp.v11.i7.316]
URL: https://www.wjgnet.com/2220-3206/full/v11/i7/316.htm
Number Citing Articles
1
Michael McCurdy, Rajkishen Narayanan, Jonathan Dalton, Chloe K. Herczeg, Jeremy Heard, Yunsoo Lee, Alec Giakas, Emma Boyajieff, Abbey Glover, Saurav Sumughan, Grace Bowen, Yoni Dulitzki, Emmanuel Dean, Mark Kurd, Jose A. Canseco, Alan S. Hilibrand, Alexander R. Vaccaro, Christopher K. Kepler, Gregory D. Schroeder. Impact of Antidepressant Use on Intraoperative Blood Loss and Transfusion Rates in Lumbar Fusion SurgeryWorld Neurosurgery 2024;  doi: 10.1016/j.wneu.2024.10.142
2
Catherine W. Bennett, Lauren Gensler, David R. Goldsmith. Antipsychotics and Medical Comorbidity: A Retrospective Study in an Urban Outpatient Psychiatry ClinicCommunity Mental Health Journal 2023; 59(4): 641 doi: 10.1007/s10597-022-01045-2
3
Daria A. Kamaeva, Daria V. Kazantseva, Anastasiia S. Boiko, Irina A. Mednova, Liudmila P. Smirnova, Elena G. Kornetova, Svetlana A. Ivanova. The Influence of Antipsychotic Treatment on the Activity of Abzymes Targeting Myelin and Levels of Inflammation Markers in Patients with SchizophreniaBiomedicines 2023; 11(4): 1179 doi: 10.3390/biomedicines11041179
4
Faiez Iqbal, Aneemaa Narayan, Mallicka Chatrath, Mohammad Iqbal. Examining the Association Between Serotonergic Antidepressants and Blood Transfusion Requirements in Orthopaedic Surgery: A Comprehensive AnalysisCureus 2023;  doi: 10.7759/cureus.45988
5
O. Godin, B. Pignon, A. Szoke, L. Boyer, B. Aouizerate, B. Schorr, M. André, D. Capdevielle, I. Chereau, N. Coulon, R. Dassing, C. Dubertret, B. Etain, S. Leignier, P.M. Llorca, J. Mallet, D. Misdrahi, C. Passerieux, R. Rey, M. Urbach, F. Schürhoff, M. Leboyer, G. Fond. 3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohortProgress in Neuro-Psychopharmacology and Biological Psychiatry 2023; 120: 110641 doi: 10.1016/j.pnpbp.2022.110641
6
Joseph Dao, Savreen Saran, Melody Wang, Christina Michael, Nhu-y Phan, Alfredo Bellon. A Systematic Review on the Potential of Aspirin to Reduce Cardiovascular Risk in SchizophreniaBrain Sciences 2023; 13(2): 368 doi: 10.3390/brainsci13020368
7
Hélène Verdoux, Clélia Quiles, Jose de Leon. Optimizing antidepressant and clozapine co-prescription in clinical practice: A systematic review and expert recommendationsSchizophrenia Research 2024; 268: 243 doi: 10.1016/j.schres.2023.10.003